The Alopecia Market Size is valued at USD 8.6 billion in 2023 and is predicted to reach USD 17.8 billion by the year 2031 at a 9.8% CAGR during the forecast period for 2024-2031.
Alopecia is an autoimmune disease that damages hair follicles and causes hair loss. The commercial landscape for medicines and treatments targeting this condition is included in the worldwide Alopecia Market. Hence, the rising cases of chronic diseases related to hair loss are expected to increase the alopecia market in the near future. The growing prevalence of hair loss and advancement in technology are factors expected to drive the growth of the global Alopecia market. Rising healthcare expenses, growing disposable income, and increasing emphasis on aesthetic appearance are some of the other factors expected to boost the market expansion in the coming years.
However, the high cost of Alopecia, negative effects of hair loss treatments, and the COVID-19 pandemic may hinder target market expansion throughout the foreseeable year. Over the forecast period, rising R&D, government initiatives to use sustainable materials, and major player investments are expected to create lucrative revenue growth opportunities for global Alopecia market players.
The Alopecia market is segmented on the basis of disease type, treatment, gender, sales channel, and end use. Based on disease type, the market is segmented as alopecia areata, cicatrical Alopecia, traction alopecia, alopecia totalis, alopecia universalis, androgenetic Alopecia, and others. By treatment, the market is segmented into pharmaceuticals and devices. The gender segment consists of male and female. As per the sales channel, the market is segmented into prescriptions and OTC. By end use, the market is segmented into homecare settings and dermatology clinics.
The alopecia areata category is expected to hold a major share of the global Alopecia market in 2023. This is attributed to growing consumer awareness about the disease. According to the National Alopecia Areata Foundation, about 147 million people globally are affected by Alopecia. Additionally, the growing development of novel therapy and favorable advantages in the process of approval are anticipated to increase market growth.
The male segment is estimated to grow at a rapid rate in the global Alopecia market owing to the increasing prevalence of hair loss in the male population globally. Hence, with the growing tobacco intake in men and an increasing aged population, there is an increase in demand for Alopecia in the healthcare hair loss sector.
The North American alopecia market is expected to report the prominent market share in terms of revenue in the near future. This can be attributed to the strong focus on hair loss disease in the region, with the increasing adoption of Alopecia. In addition, increasing adoption of laser-based therapy for treatment and rising consumer awareness is anticipated to increase the market growth. Government and non-profit organizations' initiatives to create consumer awareness in the region are factors increasing the growth of the target market. The Asia Pacific is esetimated to grow with at a rapid rate in the global Alopecia market due to growing demand for effective treatment options, government initiatives, increasing funding in various industries.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 8.6 Bn |
|
Revenue Forecast In 2031 |
USD 17.8 Bn |
|
Growth Rate CAGR |
CAGR of 9.8% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Disease Type, Treatment, Gender, Sales Channel, And End Use |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Janssen Global Services Inc., Cipla Limited, Merck & Co., Inc., GlaxoSmithKline Plc, Sun Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories Ltd, Aurobindo Pharma, Viatris Inc., Pfizer, Inc., Lilly, Lexington Intl., LLC, Freedom Laser Therapy, Curallux, LLC, Apira Science Inc., Revian Inc., Theradome, and Lutronic. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Alopecia Market Snapshot
Chapter 4. Global Alopecia Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Alopecia Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Alopecia Industry Trends
Chapter 5. Alopecia Market Segmentation 1: By Disease Type, Estimates & Trend Analysis
5.1. Market Share by Disease Type, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Type
5.2.1. Alopecia Areata
5.2.2. Cicatricial Alopecia
5.2.3. Traction Alopecia
5.2.4. Alopecia Totalis
5.2.5. Alopecia Universalis
5.2.6. Androgenetic Alopecia
5.2.7. Others
Chapter 6. Alopecia Market Segmentation 2: By Treatment, Estimates & Trend Analysis
6.1. Market Share by Treatment, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Treatments:
6.2.1. Pharmaceuticals
6.2.1.1. Topical
6.2.1.1.1. OTC
6.2.1.1.1.1. Minoxidil
6.2.1.1.1.2. Others
6.2.1.1.2. Prescription
6.2.1.1.2.1. Betamethasone Dipropionate
6.2.1.1.2.2. Fluocinolone Acetonide
6.2.1.1.2.3. Finasteride
6.2.1.1.2.4. Minoxidil
6.2.1.2. Oral
6.2.1.2.1. OTC
6.2.1.2.1.1 Prescription
6.2.1.2.1.1. Minoxidil
6.2.1.2.1.2. Finasteride
6.2.1.2.1.3. Corticosteroids
6.2.1.2.1.4. Others (JAK inhibitors and others)
6.2.1.2.2. PRP
6.2.2. Devices
6.2.2.1. Laser Cap
6.2.2.2. Laser Comb
6.2.2.3. Laser Helmet
Chapter 7. Alopecia Market Segmentation 3: By Gender, Estimates & Trend Analysis
7.1. Market Share by Gender, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Gender:
7.2.1. Male
7.2.2. Female
Chapter 8. Alopecia Market Segmentation 4: By Sales Channel, Estimates & Trend Analysis
8.1. Market Share by Sales Channel, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Sales Channel:
8.2.1. Prescriptions
8.2.2. OTC
Chapter 9. Alopecia Market Segmentation 5: By End User, Estimates & Trend Analysis
9.1. Market Share by End User, 2023 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End User:
9.2.1. Homecare Settings
9.2.2. Dermatology Clinics
Chapter 10. Alopecia Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Alopecia Market, Regional Snapshot 2023 & 2031
10.2. North America
10.2.1. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.2.3. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.2.4. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.2.5. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.2.6. North America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.3. Europe
10.3.1. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.3.3. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.3.4. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.3.5. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.3.6. Europe Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.4. Asia Pacific
10.4.1. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.4.3. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.4.4. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.4.5. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts By Sales Channel, 2024-2031
10.4.6. Asia Pacific Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.5. Latin America
10.5.1. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.5.3. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.5.4. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.5.5. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.5.6. Latin America Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
10.6. Middle East & Africa
10.6.1. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
10.6.3. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
10.6.4. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Gender, 2024-2031
10.6.5. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by Sales Channel, 2024-2031
10.6.6. Middle East & Africa Alopecia Market Revenue (US$ Million) Estimates and Forecasts by End User, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Janssen Global Services Inc.
11.2.1.1. Business Overview
11.2.1.2. Key Product/Service Offerings
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Cipla Limited
11.2.3. Merck & Co., Inc.
11.2.4. GlaxoSmithKline Plc
11.2.5. Sun Pharmaceuticals Industries Ltd
11.2.6. Dr Reddy's Laboratories Ltd
11.2.7. Aurobindo Pharma
11.2.8. Viatris Inc.
11.2.9. Pfizer, Inc.
11.2.10. Eli Lilly
11.2.11. Lexington Intl., LLC
11.2.12. Freedom Laser Therapy
11.2.13. Curallux, LLC
11.2.14. Apira Sciences Inc.
11.2.15. Revian Inc.
11.2.16. Theradome
11.2.17. Lutronic
11.2.18. iRestore Hair Growth System
11.2.19. iGrow Laser
11.2.20. Theradome
11.2.21. Other Prominent Players
Alopecia Market By Disease Type-
Alopecia Market By Treatment-
Alopecia Market By Gender-
Alopecia Market By Sales Channel-
Alopecia Market By End Use-
Alopecia Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
